Related references
Note: Only part of the references are listed.Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study
Valentina Gambacorta et al.
HAEMATOLOGICA (2021)
Development and performance of a next generation sequencing (NGS) assay for monitoring of mixed chimerism
Linnea Pettersson et al.
CLINICA CHIMICA ACTA (2021)
The Nexus of cfDNA and Nuclease Biology
Diana S. C. Han et al.
TRENDS IN GENETICS (2021)
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM-SIAPEC-IAP-SIBioC-SIC-SIF itallan Scientific Societies
A. Russo et al.
ESMO OPEN (2021)
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria et al.
HAEMATOLOGICA (2020)
Is microchimerism a sign of imminent disease recurrence after allogeneic hematopoietic stem cell transplantation? A systematic review of the literature
Anna Karen Haugaard et al.
BLOOD REVIEWS (2020)
Evaluation of host-based molecular markers for the early detection of human sepsis
Elisabeth Ullrich et al.
JOURNAL OF BIOTECHNOLOGY (2020)
Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases
Iuliia A. Polina et al.
CLINICA CHIMICA ACTA (2020)
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
Pier Edoardo Rovatti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
Ciniso Sylvester Shabangu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR
Miguel Alcaide et al.
SCIENTIFIC REPORTS (2020)
Short Tandem Repeats (STRs) as Biomarkers for the Quantitative Follow-Up of Chimerism after Stem Cell Transplantation: Methodological Considerations and Clinical Application
Almudena Navarro-Bailon et al.
GENES (2020)
Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope?
Adriana Torres Crigna et al.
EPMA JOURNAL (2020)
Isolation Methods for Human CD34 Subsets Using Fluorescent and Magnetic Activated Cell Sorting: an In Vivo Comparative Study
Himi Tripathi et al.
STEM CELL REVIEWS AND REPORTS (2020)
Personalized Chimerism Test that Uses Selection of Short Tandem Repeat or Quantitative PCR Depending on Patient's Chimerism Status
Jennifer Tyler et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2019)
Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms
Jennifer Valero-Garcia et al.
PLOS ONE (2019)
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
Jason Dehn et al.
BLOOD (2019)
Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation
Thomas Mika et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2019)
SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation
Jieun Kim et al.
ANNALS OF HEMATOLOGY (2018)
Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies
David Kliman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Cell-free DNA characteristics and chimerism analysis in patients after allogeneic cell transplantation
Jesus Duque-Afonso et al.
CLINICAL BIOCHEMISTRY (2018)
Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives
Kristina V. Glebova et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
Early achievement of full donor chimerism after allogeneic hematopoietic stem cell transplantation predicts lower relapse risk in patients with acute lymphoblastic leukemia
Chien-Ting Chen et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2018)
Architecture of polymorphisms in the human genome reveals functionally important and positively selected variants in immune response and drug transporter genes
Yu Jin et al.
HUMAN GENOMICS (2018)
Incidence of HLA Loss in a Global Multicentric Cohort of Post-Transplantation Relapses: Results from the Hlaloss Collaborative Study
Luca Vago et al.
BLOOD (2018)
Lineage-specific chimerism monitoring after allogeneic haematopoietic stem cell transplantation: do we really know what we are measuring?
Mark B. Watson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation
C. Bach et al.
BLOOD CANCER JOURNAL (2017)
Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia
Gregory W. Roloff et al.
JOURNAL OF CLINICAL MEDICINE (2017)
Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring
Philip Burnham et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2017)
Clinical Utility of Quantitative PCR for Chimerism and Engraftment Monitoring after Allogeneic Stem Cell Transplantation for Hematologic Malignancies
Mueberra Ahci et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT
Mueberra Ahci et al.
BLOOD (2017)
Current Use and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation
Miguel Waterhouse et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies
A. Liou et al.
BONE MARROW TRANSPLANTATION (2017)
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
P. Tsirigotis et al.
BONE MARROW TRANSPLANTATION (2016)
Peripheral blood late mixed chimerism in leucocyte subpopulations following allogeneic stem cell transplantation for childhood malignancies: does it matter?
Herbert Pichler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia
Sandra Preuner et al.
HAEMATOLOGICA (2016)
A technical application of quantitative next generation sequencing for chimerism evaluation
Michelangelo Aloisio et al.
MOLECULAR MEDICINE REPORTS (2016)
Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends
K. C. Allen Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia
Sandra Preuner et al.
HAEMATOLOGICA (2016)
Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
Sarah Morin-Zorman et al.
FRONTIERS IN IMMUNOLOGY (2016)
Immune Reconstitutional after Allogeneic Hematopoietic Stem Cell Transplantation
Justyna Ogonek et al.
FRONTIERS IN IMMUNOLOGY (2016)
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes
Hans C. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies
Biljana Horn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
A. Hamdi et al.
BONE MARROW TRANSPLANTATION (2015)
Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation
Tanja Stahl et al.
EXPERIMENTAL HEMATOLOGY (2015)
Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group
Jordan R. Clark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation
L. Crucitti et al.
LEUKEMIA (2015)
Monitoring of Hematopoietic Chimerism after Transplantation for Pediatric Myelodysplastic Syndrome: Real-Time or Conventional Short Tandem Repeat PCR in Peripheral Blood or Bone Marrow?
Andre M. Willasch et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT
X-Y Qin et al.
BONE MARROW TRANSPLANTATION (2014)
Chimerism Monitoring after Allogeneic Hematopoietic Stem Cell Transplantation Using Quantitative Real-Time PCR of Biallelic Insertion/Deletion Polymorphisms
Seon Young Kim et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Role of minimal residual disease and chimerism after reduced-intensity and myeloablative allo-transplantation in acute myeloid leukemia and high-risk myelodysplastic syndrome
Teresa Bernal et al.
LEUKEMIA RESEARCH (2014)
Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing
Rebecca W. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Application of Next-generation Sequencing Technology in Forensic Science
Yaran Yang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2014)
CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT
F. Rosenow et al.
BONE MARROW TRANSPLANTATION (2013)
Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant
E. Nikolousis et al.
LEUKEMIA RESEARCH (2013)
Assessment of the purity of isolated cell populations for lineage-specific chimerism monitoring post haematopoietic stem cell transplantation
V. Hanson et al.
TISSUE ANTIGENS (2013)
Genomic loss of patient-specific HLA in acute myeloid leukemia relapse after well-matched unrelated donor HSCT
Cristina Toffalori et al.
BLOOD (2012)
The practical application of chimerism analyses in allogeneic stem cell transplant recipients: Blood chimerism is equivalent to marrow chimerism
Cocav A. Rauwerdink et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation
S. Breuer et al.
LEUKEMIA (2012)
Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation
Miguel Waterhouse et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis
A. Willasch et al.
BONE MARROW TRANSPLANTATION (2010)
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation
Martin Bornhaeuser et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Single Nucleotide Polymorphism-Based System Improves the Applicability of Quantitative PCR for Chimerism Monitoring
Egle Gineikiene et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation.
Luca Vago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lack of utility of chimerism studies obtained 2-3 months after myeloablative hematopoietic cell transplantation for ALL
K. C. Doney et al.
BONE MARROW TRANSPLANTATION (2008)
Mixed chimerism in SCT: conflict or peaceful coexistence?
J. L. Liesveld et al.
BONE MARROW TRANSPLANTATION (2008)
Statistical significance of quantitative PCR
Yann Karlen et al.
BMC BIOINFORMATICS (2007)
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
F. Baron et al.
LEUKEMIA (2006)
Analysis of donor-type chimerism in lineage-specific cell populations after allogeneic myeloablative and nonmyeloablative stem cell transplantation
Y Miura et al.
BONE MARROW TRANSPLANTATION (2006)
Long-term persistence of host cells detected by X-chromosome gene-based assay in patients undergoing gender-mismatched hematopoietic stem cell transplantation
M Karasawa et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease
J Balon et al.
BONE MARROW TRANSPLANTATION (2005)
How and when should we monitor chimerism after allogeneic stem cell transplantation?
P Bader et al.
BONE MARROW TRANSPLANTATION (2005)
Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective
P Bader et al.
BONE MARROW TRANSPLANTATION (2004)
Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme
F Khan et al.
BONE MARROW TRANSPLANTATION (2004)
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
F Baron et al.
BLOOD (2004)
Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation
C Thiede et al.
ACTA HAEMATOLOGICA (2004)
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy?
P Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning:: potential predictive value of NK cell chimaerism for late graft rejection
S Matthes-Martin et al.
LEUKEMIA (2003)
Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction
M Alizadeh et al.
BLOOD (2002)
Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations
A Shimoni et al.
LEUKEMIA (2001)
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation
J Mattsson et al.
LEUKEMIA (2001)
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation
J Mattsson et al.
TRANSPLANTATION (2001)
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers
C Thiede et al.
LEUKEMIA (2001)
Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation
T Lion et al.
LEUKEMIA (2001)
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings
JH Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study
SJ Choi et al.
BONE MARROW TRANSPLANTATION (2000)
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia
H Zetterquist et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
